CGI
ELV icon

CI Global Investments’s Elevance Health ELV Stock Holding History

CI Global Investments’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$358M Sell
1,305,045
-260,017
-17% -$67.5M 5.5% 7
2018
Q2 		$373M Buy
1,565,062
+789,632
+102% +$183M 6.01% 4
2018
Q1 		$170M Buy
+775,430
New +$182M 2.93% 10

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CI Global Investments's ELV Position: Q3 2018 in Review

CI Global Investments reduced its Elevance Health (ELV) stake by 17% in Q3 2018, selling an estimated $67.5M and leaving 1,305,045 shares worth $358M. The position accounts for 5.5% of the portfolio, ranked #7.

CI Global Investments first reported a position in ELV in Q1 2018 and has held it in 3 quarters since. The position peaked at $373M in Q2 2018. 946 funds tracked by Wall St. Rank hold ELV as of Q3 2018.

  • CI Global Investments held 1,305,045 shares of Elevance Health worth $358M as of Q3 2018.
  • CI Global Investments sold 260,017 Elevance Health shares in Q3 2018, an estimated $67.5M.
  • Elevance Health made up 5.5% of CI Global Investments's portfolio in Q3 2018, its #7 holding.
  • CI Global Investments first reported a position in Elevance Health in Q1 2018 and has held it in 3 quarters since.
  • CI Global Investments's Elevance Health position peaked at $373M in Q2 2018.
  • 946 funds tracked by Wall St. Rank held Elevance Health as of Q3 2018.

Based on CI Global Investments's 13F filing for Q3 2018, filed 9 Nov 2018.